Tuija Tapaninen

8PUBLICATIONS
19CO-AUTHORS
Gene and molecular therapyPharmacogenomicsHaematological tumoursGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 02, 2026
Identification of a Functional CYP2C8 Variant Allele that Alters Splicing, Reduces Protein Expression, and Increases Drug Exposure.

|Mar 03, 2025
Identification of Genetic Variants Associated with Pravastatin and Pitavastatin Pharmacokinetics.

Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen

|Sep 28, 2024
Complex Relationships between Diagnostics and Survival in Chronic Lymphocytic Leukemia in Denmark, Finland, Norway, and Sweden.

Kari Hemminki, Frantisek Zitricky, Asta Försti

|Mar 17, 2024
Genome-Wide Association Study of Atorvastatin Pharmacokinetics: Associations With SLCO1B1, UGT1A3, and LPP.

Anssi J H Mykkänen, E Katriina Tarkiainen, Suvi Taskinen

|Jun 02, 2022
Genomewide Association Study of Simvastatin Pharmacokinetics.

Anssi J H Mykkänen, Suvi Taskinen, Mikko Neuvonen

|Sep 29, 2021
Pharmacogenomics of celiprolol - evidence for a role of P-glycoprotein and organic anion transporting polypeptide 1A2 in celiprolol pharmacokinetics.

Päivi Hirvensalo, Aleksi Tornio, Tuija Tapaninen

Pageof 2

Frequent Collaborators

7 joint publications

Aleksi Tornio

7 joint publications

Mikko Niemi

7 joint publications

Janne T Backman

4 joint publications

Anssi J H Mykkänen